Palbociclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer
Technology appraisal guidance
Reference number: TA495
Published:
Tools and resources
Tools and resources to help you put the guidance into practice.